The active ingredient in Ozempic was associated with a reduced risk of Alzheimer's disease-related dementia among diabetes patients.

Ozempic Linked With Lower Dementia Risk, Nicotine Use, British Study Finds (Reuters) - Novo Nordisk's popular diabetes treatment Ozempic could be tied to a lower risk of cognitive problems ...

The exact numbers depended on the type of medication patients took, but the risk of developing Alzheimer’s was up to 70 ...

Diabetics are more likely to develop Alzheimer’s than the general public. Could a popular diabetes and weight-loss drug also ...

Meanwhile, an analysis of 26 trials — with a total of 164,531 participants — also published in JAMA Neurology today had similar findings, linking GLP-1 drugs to a 45% lower risk of dementia.

New research suggests that the diabetes drug and popular weight loss treatment semaglutide, commonly known as Ozempic and Wegovy, is linked with a lower risk of dementia — possibly adding to the ...

Published in Alzheimer’s & Dementia on Thursday, Oct. 24, the study found that semaglutide — the active ingredient in popular weight loss drugs like Ozempic and Wegovy — may be linked to ...

Ozempic linked to lower Alzheimer's risk in people with Type 2 diabetes. Story by Berkeley Lovelace Jr. ... found that semaglutide appeared to cut the risk of dementia in people with Type 2 diabetes.

Ozempic linked with lower dementia risk, nicotine use, British study finds. By Reuters. July 12, 2024 5:49 PM UTC Updated July 12, 2024 A box of Ozempic and contents sit on a table ...

According to a study published on October 24, 2024, in the journal Alzheimer’s & Dementia, the type 2 diabetes and weight loss drug semaglutide (sold under the brand names Ozempic, Wegovy, and ...

Ozempic and similar novel diabetes treatments may lower the risk of Alzheimer's disease and related dementias.. This is the conclusion of a pair of studies by research teams from the U.S. and ...